FOLLICLE CENTRE LYMPHOMA, FOLLICULAR GRADE I, II, III REFRACTORY

This adverse event was reported 8 times

FOLLICLE CENTRE LYMPHOMA, FOLLICULAR GRADE I, II, III REFRACTORY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 IBRITUMOMAB TIUXETAN 2 0.0013
1 BENDAMUSTINE HCL 2 0.0001
2 CLADRIBINE 1 0.0001
3 DOXORUBICIN HYDROCHLORIDE 3 0.0001
4 MELPHALAN HYDROCHLORIDE 2 0.0001
5 DOXORUBICIN 6 0.0001
6 EVEROLIMUS TABLETS 1 0.0001
7 FLUDARABINE PHOSPHATE 2 0.0001
8 EVEROLIMUS 2 0.0000
9 CYCLOPHOSPHAMIDE FOR INJECTION 7 0.0000
See all drugs enriched for association with FOLLICLE CENTRE LYMPHOMA, FOLLICULAR GRADE I, II, III REFRACTORY

FOLLICLE CENTRE LYMPHOMA, FOLLICULAR GRADE I, II, III REFRACTORY is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Alkylating Drug [EPC] 7 0.0000
1 Topoisomerase Inhibitor [EPC] 2 0.0000
2 CD20-directed Cytolytic Antibody [EPC] 7 0.0000
3 Purine Antimetabolite [EPC] 1 0.0000
4 Calcineurin Inhibitor Immunosuppressant [EPC] 1 0.0000
5 Nucleoside Metabolic Inhibitor [EPC] 2 0.0000
6 Corticosteroid [EPC] 7 0.0000
7 Folate Analog Metabolic Inhibitor [EPC] 2 0.0000
8 Kinase Inhibitor [EPC] 2 0.0000
See all drug classes enriched for association with FOLLICLE CENTRE LYMPHOMA, FOLLICULAR GRADE I, II, III REFRACTORY